Preview

Артериальная гипертензия

Расширенный поиск

Прогностическое значение высокого артериального давления в период беременности

https://doi.org/10.18705/1607-419X-2008-14-1-22-26

Полный текст:

Аннотация

В последние годы появилась информация о том, что развитие артериальной гипертензии во время беременности является фактором риска возникновения сердечно-сосудистых заболеваний в будущем. По-видимому, несмотря на то, что в популяции молодых женщин сердечно-сосудистый риск невысок, наличие артериальной гипертензии и особенно преэклампсии в период беременности способствует многократному увеличению риска кардиоваску-лярной патологии в будущем.

Об авторах

Е. Баранова
Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова
Россия


О. Большакова
Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова
Россия


Список литературы

1. Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension 2007; 25: 1105-1187.

2.

3. The Task Force on the Management of cardiovascular Diseases During Pregnancy on European Society of Cardiology. Expert consensus documents on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761-781.

4.

5. Маслова Н.П., Баранова Е.И. Гипертоническая болезнь у женщин. - СПб.: Издательство СПбГМУ, 2000. 216 с.

6.

7. Wilson B.J., Watson M.S., Prescott G.J. et al. Hypertensive disease of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br Med J 2003; 326 (7394): 845.

8.

9. Jonsdottir L.S., Arngrimsson R., Geirsson R.T., Sigvaldason H., Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74 (10): 772-776.

10.

11. Arnadottir G.A., Geirsson R.T., Arngrimsson R., Jonsdottir L.S., Olafsson O. Cariovascular death in women who had hypertension in pregnancy: a case-control study. BJOG 2005; 112:286-292.

12.

13. Irgens H.U., Reisaeter L., Irgens L.M., Lie R.T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2001; 323 (7323): 1213-1217.

14.

15. Sibai B.M., Lindheimer M.D., Hauth J. et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998; 339:667-671.

16.

17. Roberts J. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 5-15.

18.

19. Roberts J.M., Hubel C.A. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 1999; 354: 788-789.

20.

21. Hayman R. Hypertension in pregnancy. Curr Obstet Gynaecol 2004; 14(1): 1-10.

22.

23. Choi J.W., Im M.W., Pai S.H. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002; 32 (3): 257-263.

24.

25. Vural P. Nitric oxide/endothelin-1 in preeclampsia. Clin Chim Acta 2002; 317 (1-2): 65-70.

26.

27. Rodie V.A., Freeman D.J., Sattar N., Greer L.A. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004; 175:189-202.

28.

29. Naccasha N., Gervasi M.T., Chaiworapongsa T., et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001; 185(5): 1118-1123.

30.

31. Von Dadelszen P., Watson R.W., Noorwali F., et al. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauteric growth restriction. Am J Obstet Gynecol 1999; 18 (2): 408-414.

32.

33. Carr D.B., McDonald G.B., Brateng D., Desai M., Thach C.T., Easterling T.R. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstet Gynecol 2001; 98 (6): 1109-1116.

34.

35. Zeisler H., Livingston J.C., Schatten C., Tempfer C., Knofler M., Husslein P. Serum levels of adhesion molecules in woment with pregnancy-induced hypertension. Wien Klin Wochenschr 2001; 113 (1516): 588-592.

36.

37. Longo S.A., Dola C.P., Pridjian G. Preeclampsia and eclampsia revisited. South Med J 2003; 96 (9): 891-899.

38.

39. Greenwood J.P., Scott E.M., Stoker J.В., et al. Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans. Circulation 2001; 104: 2200-2204.

40.

41. Itakura A., Mizutani S. Involvement of placental peptidases associated with renin-angiotensin systems in preeclampsia. Biochim Biophys Acta 2005; 1:1751.

42.

43. Groenendijk R., Trimbos J.В., Wallenburg H.C.Hemodynamic measurements in preeclampsia: preliminaryobservation. Am J Obstet Gynecol 1984; 150 (3): 232-236.

44.

45. Clark S.L., Cotton D.B. Clinical indications for pulmonaryartery catheterization in the patients with severe preeclampsia. AmJ Obstet Gynecol 1988; 158 (3): 453-458.

46.

47. Gant N.F., Chand S., Whalley P.J., MacDonald P.C. The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974; 43 (6): 854.

48.

49. Baker P.N., Broughton Pipkin F., Symonds E.M. Platelet angiotensin II binding sites in normotensive and hypertensive women. Br J Obstet Gynecol 1991; 98 (5): 436-440.

50.

51. Bobst S.M., Day M-C., Gilstrap L. C., Xia Y., Kellems R.E. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am. J Hypert 2005; 18 (3): 330-336.

52.

53. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia current concepts Am J Obstet Gynecol 1998; 179: 1359-1375.

54.

55. Working Group Report on High Blood Pressure in Pregnancy. J Clin Hypertens 2001; 3 (2): 75-88.

56.

57. Rodie V.A., Freeman D.J., Sattar N., Greer I.A. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004; 175: 189-202.

58.

59. He S., Siveira A., Hamsten A., Blomback M., Bremme K. Haemotstatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Heaemost 1999; 81 (4): 538-542.

60.

61. Laivuori H., Tikkanen M.J., Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81 (8): 2908-2911.

62.

63. Belo L., Caslake M., Gaffney D., et al. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis 2002; 162 (2): 425-532.

64.

65. Ogura K., Miyatake Т., Fukui O., Nakamura Т., Kameda Т., Yoshino G. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb 2002; 9(1): 42-47.

66.

67. Sattar N., Clark P., Greer I.A., Shepherd J., Packard C.J.Lipoprotein (a) levels in normal pregnancy and in pregnancycomplicated with pre-eclampsia. Atherpsclerosis 2000; 148 (2):407-411.

68.


Для цитирования:


Баранова Е., Большакова О. Прогностическое значение высокого артериального давления в период беременности . Артериальная гипертензия. 2008;14(1):22-26. https://doi.org/10.18705/1607-419X-2008-14-1-22-26

For citation:


Baranova E., Bolshakova O. Prognostic values of high blood pressure duringpregnancy . "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2008;14(1):22-26. (In Russ.) https://doi.org/10.18705/1607-419X-2008-14-1-22-26

Просмотров: 65


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)